Andrew S. Plump
Director, President-Research & Development
|
Chris Slavinsky
VP-External Innovation & Head-Gastroenterology
|
Christophe Weber
President, CEO & Representative Director
|
Christopher David O'Reilly
Global Head-Investor Relations
|
Emiko Higashi
Independent Outside Director
|
Gabriele Ricci
Chief Data & Technology Officer
|
Giles Platford
President-Europe & Canada
|
Haruhiko Hirate
Corporate Communications & Public Affairs Officer
|
Ian T. Clark
Independent Director
|
Jean-Luc Butel
Independent Outside Director
|
John M. Maraganore
Independent Outside Director
|
Julie So-Young Kim
President-Plasma-Derived Therapies
|
Kimberly A. Reed
Independent Outside Director
|
Koji Hatsukawa
Independent Outside Director
|
Lauren Duprey
Chief Human Resources Officer
|
Marcello Agosti
Global Business Development Officer
|
Mark Etherton
Medical Director
|
Masami Iijima
Chairman
|
Michael E. Mendelsohn
Chief Medical & Scientific Officer
|
Michel Orsinger
Independent Outside Director
|
Miki Tsusaka
Independent Outside Director
|
Milano Furuta
Chief Financial Officer & Director
|
Mwana Lugogo
Chief Ethics & Compliance Officer
|
Norimasa Takeda
Chief Accounting Officer & Corporate Controller
|
Ramy Riad
CFO-Global Plasma Derived Therapies
|
Ricardo Marek
President-Growth & Emerging Markets Business Unit
|
Rupa Cornell
Vice President-Legal
|
Salvatore Alesci
Head-R & D Global Science & Biomedical Policy
|
Satoru Takemoto
General Manager-Sales
|
Steven H. Gillis
Independent Outside Director
|
Takashi Okubo
Global Head-Investor Relations & Global Finance
|
Teresa Bitetti
President-Global Oncology Business Unit
|
Yoshiaki Fujimori
Independent Outside Director
|
Yoshihiro Nakagawa
Executive Officer & Global General Counsel
|
